logo









Genomatica

Genomatica



Genomatica is a biotechnology company that develops commercial biobased processes to produce essential chemicals for sustainable everyday products.
Sign up today to get real-time market insights on Genomatica and hundreds of other pre-IPO companies



Genomatica Overview

San Diego, CA, United States
1998
Biotech



Genomatica Live Market Data

$00000000
$00000000




Genomatica Funding Rounds



RoundDateAmount RaisedValuationInvestorsSources
Later Stage3/20/2023
Series C7/27/2021
Series B10/5/2018
Series A9/12/2016
Later Stage7/11/2013
Series D
8/2/2012




Genomatica Investors



InvestorInvestment RoundsLead PartnerInitial InvestmentOther Notable Investments
Draper Fisher Jurvetson ManagementSeries B, Series C, Series D, Series C1Series B (2008-05-13)
TPG (NAS: TPG)Series C, Series D, Series C1Series C (2010-03-25)
TriplePoint CapitalSeries CSeries C (2010-03-25)
Viking Global InvestorsLater Stage VC, Series C, Series B, Series ALater Stage VC (2013-07-11)
Irving InvestorsSeries CSeries C (2021-07-27)
Novo HoldingsSeries CSeries C (2021-07-27)
Spur Capital Partners
Series C
Series C (2021-07-27)




Genomatica 409a Valuations



DatePrice per shareEst. ValuationFilling
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Sign up to access Genomatica data




Genomatica Filings



TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign up to access Genomatica data










DisclaimerAll investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.